Definition of key events -: Last attempt?

被引：5

作者：

Burrougbs, Andrew K. ^{[1
]}

Calès, Paul ^{[1
]}

Kravetz, David ^{[2
]}

Riggio, Oliviero ^{[3
]}

Thabut, Dominique ^{[4
]}

van Buuren, Henk R. ^{[5
]}

Kamath, Patrick S. ^{[6
]}

机构：

[1] Univ Angers, 49933 Angers Cedex 9, Angers, France

[2] Univ Calif San Diego, Div Gastroenterol, VA San Diego Healthcare System, La Jolla, CA 92093 USA

[3] Univ Roma La Sapienza, Dept Clin Med, Div Gastroenterol 2, Rome, Italy

[4] Hop La Pitie Salpetriere, Paris, France

[5] Erasmus MC Univ Hosp, Rotterdam, Netherlands

[6] Mayo Clin Coll Med, Rochester, MN 55905 USA

来源：

PORTAL HYPERTENSION IV | 2006年

关键词：

D O I：

10.1002/9780470988831.ch2

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：11 / +

页数：4

共 26 条

[1]

[Anonymous], COCHRANE DATABASE SY

[2] Early administration of somatostatin and efficacy of sclerotherapy in acute oesophageal variceal bleeds: the European acute bleeding oesophageal variceal episodes (ABOVE) randomised trial [J].

Avgerinos, A ;

Nevens, F ;

Raptis, S ;

Fevery, J ;

Armonis, A ;

Manolakopoulos, S ;

Poulianos, G ;

Tzathas, C ;

Katsaros, D ;

Soutos, D ;

Zacharopoulose, A ;

Adler, M ;

Bourgeois, N ;

Bac, DJ ;

VanBuuren, HR ;

Decruyenaere, J ;

Elewaut, A ;

Deman, M ;

Lepoutre, L ;

VanderSpek, P ;

Hautekeete, M ;

Reynaert, H ;

Buyse, M ;

Ritter, L ;

Burtin, B ;

Darcis, T ;

Ioannou, J ;

Natens, J ;

Natens, O .

LANCET, 1997, 350 (9090) :1495-1499

[3]

Bernard B, 1997, HEPATOLOGY, V25, P63, DOI 10.1053/jhep.1997.v25.pm0008985266

[4] Recombinant factor VIIa for upper gastrointestinal bleeding in patients with cirrhosis: A randomized, double-blind trial [J].

Bosch, J ;

Thabut, D ;

Bendtsen, F ;

D'Amico, G ;

Albillos, A ;

Abraldes, JG ;

Fabricius, S ;

Erhardtsen, E ;

De Franchis, R .

GASTROENTEROLOGY, 2004, 127 (04) :1123-1130

[5] Current management of portal hypertension [J].

Bosch, J ;

Abraldes, JG ;

Groszmann, R .

JOURNAL OF HEPATOLOGY, 2003, 38 :S54-S68

[6] Assessment of value of consensus definitions in acute variceal bleeding [J].

Burroughs, AK .

LANCET, 2001, 357 (9263) :1147-1148

[7] Therapeutic benefit of vaso-active drugs for acute variceal bleeding: A real pharmacological effect, or a side-effect of definitions in trials? [J].

Burroughs, AK ;

Patch, D .

HEPATOLOGY, 1996, 24 (03) :737-739

[8] Prospective study on the application of the Baveno II Consensus Conference criteria in patients with cirrhosis and gastrointestinal bleeding [J].

Calès, P ;

Lacave, N ;

Silvain, C ;

Vinel, JP ;

Besseghir, K ;

Lebrec, D .

JOURNAL OF HEPATOLOGY, 2000, 33 (05) :738-741

[9] Early administration of vapreotide for variceal bleeding in patients with cirrhosis [J].

Calés, P ;

Masliah, C ;

Bernard, B ;

Garnier, P ;

Silvain, C ;

Szostak-Talbodec, N ;

Bronowicki, J ;

Ribard, D ;

Botta-Fridlund, D ;

Hillon, P ;

Besseghir, K ;

Lebrec, D .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (01) :23-28

[10] Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators [J].

D'Amico, G ;

De Franchis, R .

HEPATOLOGY, 2003, 38 (03) :599-612

← 1 2 3 →